The U.S. Food and Drug Administration (FDA) will give priority status to an over-the-counter opium overdose antidote nasal spray submitted for review, the pharmaceutical company said Monday. The over-the-counter naloxone nasal spray is needed to combat the synthetic opioid fentanyl, which is linked to tens of thousands of annual overdose deaths in the United States….